Wansheng Long

Dr. Wansheng Long


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
ECEnming Cui
Enming Cui
ZLZhuoyong Li
Zhuoyong Li
CMChangyi Ma
Changyi Ma
QLQing Li
Qing Li
YLYi Lei
Yi Lei
FLFan Lin
Fan Lin

17 February 2019 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
ZLZhuangsheng Liu
Zhuangsheng Liu
BFBao Feng
Bao Feng
CLChanglin Li
Changlin Li
YCYehang Chen
Yehang Chen
QCQinxian Chen
Qinxian Chen
WLWansheng Long
Wansheng Long

25 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
BFBao Feng
Bao Feng
JSJiangfeng Shi
Jiangfeng Shi
LHLiebin Huang
Liebin Huang
ZYZhiqi Yang
Zhiqi Yang
SFShi-Ting Feng
Shi-Ting Feng
WLWansheng Long
Wansheng Long
The prediction of patient disease risk via computed tomography (CT) images and artificial intelligence techniques shows great potential. However, training a robust artificial intelligence model typically requires large-scale data support. In practice, the collection of medical data faces obstacles related to privacy protection. Therefore, the present study aims to establish a robust federated learning model to overcome the data island problem and identify high-risk patients with postoperative gastric cancer recurrence in a multicentre, cross-institution setting, thereby enabling robust treatment with significant value. In the present study, we collect data from four independent medical institutions for experimentation. The robust federated learning model algorithm yields area under the receiver operating characteristic curve (AUC) values of 0.710, 0.798, 0.809, and 0.869 across four data centres. Additionally, the effectiveness of the algorithm is evaluated, and both adaptive and common features are identified through analysis.

29 August 2017 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XZXin Zhang
Xin Zhang
LZLan Zhang
Lan Zhang
BLBihua Lin
Bihua Lin
XCXingxing Chai
Xingxing Chai
RLRonggang Li
Ronggang Li
YHYanming Huang
Yanming Huang
Phospholipid phosphatase 4 (PPAPDC1A or PLPP4) has been demonstrated to be involved in the malignant process of many cancers. The purpose of this study was to investigate the clinical significance and biological roles of PLPP4 in lung carcinoma. PLPP4 expression was examined in 8 paired lung carcinoma tissues by real-time PCR and in 265 lung carcinoma tissues by immunohistochemistry (IHC). Statistical analysis was performed to evaluate the clinical correlation between PLPP4 expression and clinicopathological features and survival in lung carcinoma patients. In vitro and in vivo assays were performed to assess the biological roles of PLPP4 in lung carcinoma. Fluorescence-activated cell sorting, Western blotting and luciferase assays were used to identify the underlying pathway through which PLPP4 silencing mediates biological roles in lung carcinoma. PLPP4 is differentially elevated in lung adenocarcinoma (ADC) and lung squamous cell carcinoma (SQC) tissues. Statistical analysis demonstrated that high expression of PLPP4 significantly and positively correlated with clinicopathological features, including pathological grade, T category and stage, and poor overall and progression-free survival in lung carcinoma patients. Silencing PLPP4 inhibits proliferation and cell cycle progression in vitro and tumorigenesis in vivo in lung carcinoma cells. Our results further reveal that PLPP4 silencing inhibits Ca2+-permeable cationic channel, suggesting that downregulation of PLPP4 inhibits proliferation and tumorigenesis in lung carcinoma cells via reducing the influx of intracellular Ca2+. Our results indicate that PLPP4 may hold promise as a novel marker for the diagnosis of lung carcinoma and as a potential therapeutic target to facilitate the development of novel treatment for lung carcinoma.

1 July 2020 in European Journal of Radiology
Verified
Journal Article
Closed access
BFBao Feng
Bao Feng
XCXiangmeng Chen
Xiangmeng Chen
YCYehang Chen
Yehang Chen
KLKunfeng Liu
Kunfeng Liu
KLKunwei Li
Kunwei Li
WLWansheng Long
Wansheng Long

27 June 2020 in European Radiology
Verified
Journal Article
Open access
PDF file
BFBao Feng
Bao Feng
XCXiangMeng Chen
XiangMeng Chen
YCYeHang Chen
YeHang Chen
SLSenLiang Lu
SenLiang Lu
KLKunFeng Liu
KunFeng Liu
XLXueguo Liu
Xueguo Liu
Objectives To evaluate the differential diagnostic performance of a computed tomography (CT)-based deep learning nomogram (DLN) in identifying tuberculous granuloma (TBG) and lung adenocarcinoma (LAC) presenting as solitary solid pulmonary nodules (SSPNs). Methods Routine CT images of 550 patients with SSPNs were retrospectively obtained from two centers. A convolutional neural network was used to extract deep learning features from all lesions. The training set consisted of data for 218 patients. The least absolute shrinkage and selection operator logistic regression was used to create a deep learning signature (DLS). Clinical factors and CT-based subjective findings were combined in a clinical model. An individualized DLN incorporating DLS, clinical factors, and CT-based subjective findings was constructed to validate the diagnostic ability. The performance of the DLN was assessed by discrimination and calibration using internal (n = 140) and external validation cohorts (n = 192). Results DLS, gender, age, and lobulated shape were found to be independent predictors and were used to build the DLN. The combination showed better diagnostic accuracy than any single model evaluated using the net reclassification improvement method (p < 0.05). The areas under the curve in the training, internal validation, and external validation cohorts were 0.889 (95% confidence interval [CI], 0.839–0.927), 0.879 (95% CI, 0.813–0.928), and 0.809 (95% CI, 0.746–0.862), respectively. Decision curve analysis and stratification analysis showed that the DLN has potential generalization ability. Conclusions The CT-based DLN can preoperatively distinguish between LAC and TBG in patients presenting with SSPNs. Key Points • The deep learning nomogram was developed to preoperatively differentiate TBG from LAC in patients with SSPNs. • The performance of the deep learning feature was superior to that of the radiomics feature. • The deep learning nomogram achieved superior performance compared to the deep learning signature, the radiomics signature, or the clinical model alone.